文献速递皮肤肿瘤

反射式共聚焦显微镜识别维莫德吉治疗期间及治疗后亚临床基底细胞癌

Reflectance confocal microscopy identification of subclinical basal cell carcinomas during and after vismodegib treatment.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-11-09

本研究评估临床、皮肤镜和反射式共聚焦显微镜(RCM)在维莫德吉治疗多发性基底细胞癌(BCC)过程中检测BCC的敏感性和特异性。RCM对残留BCC的敏感性为95%,显著高于皮肤镜(35%)和临床检查(33%),特异性略低(81% vs 88%和86%)。结论认为RCM可无创检测亚临床残留BCC,有助于识别肿瘤不完全消退。

要点

  • RCM检测残留BCC的敏感性达95%,远高于皮肤镜和临床检查。
  • RCM特异性为81%,略低于皮肤镜和临床检查。
  • RCM有助于在维莫德吉治疗期间及治疗后识别亚临床残留BCC。

核心结论

  • RCM是一种无创技术,可在维莫德吉治疗期间及治疗后检测亚临床残留BCC,帮助临床医生识别肿瘤不完全消退。

研究设计与样本

  • 针对38个活检病灶计算敏感性及特异性,并对全部710次检查的BCC诊断进行比较(卡方检验)。

主要发现

  • 在38个活检病例中,RCM、皮肤镜和临床检查识别残留BCC的敏感性分别为95%、35%和33%,特异性分别为81%、88%和86%。
  • 在全部710次观察中,RCM正确诊断的BCC数量多于皮肤镜和临床检查。

关键数值与推荐

  • RCM敏感性95%,皮肤镜35%,临床检查33%;RCM特异性81%,皮肤镜88%,临床检查86%(38个活检病例)。

临床怎么用

  • 在维莫德吉治疗多发性BCC时,可采用RCM无创监测亚临床残留病灶,辅助判断肿瘤是否不完全消退。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recently, it has been shown that reflectance confocal microscopy (RCM) could identify subclinical basal cell carcinoma (BCC) during vismodegib treatment of locally advanced BCC. OBJECTIVES: To evaluate specificity and sensitivity of clinical, dermoscopic and RCM examination for BCC in patients with multiple BCCs treated by vismodegib. METHODS: Ninety four BCCs had 710 clinical, dermoscopic and RCM examinations during 72 weeks of vismodegib treatment. Thirty-eight were biopsied at the end of the treatment. Sensitivity and specificity for these 38 lesions were calculated. BCC diagnoses of clinical, dermoscopic and RCM examination on all the 710 investigations were compared using chi-square test. RESULTS: Reflectance confocal microscopy was extremely more sensitive than dermoscopy and clinical examination and slightly less specific (sensitivity of 95%, 35% and 33% and specificity of 81%, 88% and 86% for RCM, dermoscopy and clinical examination, respectively) for the identification of residual BCC in the 38 biopsied cases. Considering all the 710 observations, RCM correctly diagnosed more BCCs than dermoscopy and clinical examination. CONCLUSION: Reflectance confocal microscopy is a non-invasive technique that can detect subclinical residual BCC during and after vismodegib treatment helping the clinician to identify incomplete tumour regression.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Couzan C, Cinotti E, Labeille B, et al. Reflectance confocal microscopy identification of subclinical basal cell carcinomas during and after vismodegib treatment. J Eur Acad Dermatol Venereol. 2017. PMID: 29055164. doi:10.1111/jdv.14650

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。